| Lung Cancer |
1 |
1 |
| Non-Small Cell Lung Cancer |
0 |
0.99 |
| Biologic Therapy |
0 |
0.59 |
| Genomic Medicine |
0 |
0.5 |
| Small Cell Lung Cancer |
0 |
0.48 |
| Cancer |
0 |
0.45 |
| Chemotherapy |
0 |
0.38 |
| Lung |
0 |
0.3 |
| Clinical Research |
0 |
0.23 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.23 |
| Platinum |
0 |
0.23 |
| Clinical Guidelines |
0 |
0.13 |
| Health Care Reform |
0 |
0.08 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Outpatient Clinic |
0 |
0.07 |